You Position: Home > Paper
Combination of sodium ozagrel, aspirin and low molecular heparin calcium for patients with NSTEACS
( views:262, downloads:4 )
- Author:
- No author available
- Journal Title:
- CHINA MEDICINE
- Issue:
- 5
- DOI:
- 10.3760/cma.j.issn.1673-4777.2009.05.008
- Key Word:
- 非ST段抬高型急性冠状动脉综合征;奥扎格雷钠;阿司匹林;低分子肝素钙;Non-ST segment elevation acute coronary syndrome;Sodium ozagrel;Aspirin;Low molecular heparin calcium
Abstract： Objective To explore the efficacy and safety of a combination of sodium ozagrel, aspirin and low molecular heparin calcium for patients with NSTEACS. Methods A total of 30 patients received aspirin and low molecular heparin calcium and 30 received aspirin and low molecular heparin plus sodium ozagrel. Results The therapeutic effect in sodium ozagrel group was significandy better than in control group (P<0.05). All blood clotting indexes and adverse reactions showed no significant difference between the two groups (P 0. 05). Conclusion The combination of aspirin and low molecular heparin calcium plus sodium ozagrel showes better outcome and safety for patients with NSTEACS.
- [1]陈春红,尹博英,肖暖,等.瑞替普酶联合低分子肝素治疗急性心肌梗死28例临床观察[J].2006,(5).
- [2]冯玉萍,张蓉,吴素华,等.急性冠脉综合征死亡危险因素分析[J].2007,(12).
- [3]高海英,米纪平.氯吡格雷、阿司匹林和依诺肝素三联治疗非ST段抬高型急性冠脉综合征疗效观察[J].2005,(3).
- [4]王丽杰,孙正琦,宋颖.肺源性心脏病血栓前状态及奥扎格雷抗凝疗效分析[J].2006,(2).
- [5]李方,方征,胡燕燕,等.低分子肝素对无症状性心肌缺血及其血液流变学的影响[J].2004,(4).
- [6]师俊萍,章莹.奥扎格雷钠治疗急性脑梗死疗效观察[J].2006,(6).
- [7]葛华,李巍.急性脑梗死患者外周血血小板表面P-选择素阳性表达率变化及药物干预影响[J].2005,(12).
- [8]Masayuki NAKAZAWA,Kinji IIZUKA,Arao UJIIE,etc.Research and Development of Ozagrel, a Highly Selective Inhibitor of TXA<SUB>2</SUB> Synthase[J].1994,114(12).
- [9]Watanabe K,Kawada H,Sueda S,etc.Intracoronary administration of a thromboxane A2 synthase inhibitor relieves acetylcholine-induced coronary spasm.[J].2002,66(9).
- [10]E P, Gurfinkel,E J, Manos,R I, Mejaíl,etc.Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia.[J].1995,26(2).